<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28248924</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2052-4463</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><PubDate><Year>2017</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Scientific data</Title><ISOAbbreviation>Sci Data</ISOAbbreviation></Journal><ArticleTitle>MicroRNA screening identifies miR-134 as a regulator of poliovirus and enterovirus 71 infection.</ArticleTitle><Pagination><StartPage>170023</StartPage><MedlinePgn>170023</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">170023</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/sdata.2017.23</ELocationID><Abstract><AbstractText>MicroRNAs (miRNAs) regulate virus replication through multiple mechanisms. Poliovirus causes a highly debilitating disease and though global efforts to eradicate polio have sharply decreased polio incidence, unfortunately three countries (Afghanistan, Nigeria and Pakistan) remain polio-endemic. We hypothesize that understanding the host factors involved in polio replication will identify novel prophylactic and therapeutic targets against polio and related viruses. In this data set, employing genome wide screens of miRNA mimics and inhibitors, we identified miRNAs which significantly suppressed polio replication. Specifically, miR-134 regulates poliovirus replication via modulation of ras-related nuclear protein (RAN), an important component of the nuclear transport system. MiR-134 also inhibited other Picornaviridae viruses including EV71, a growing concern and a high priority for vaccination in Asian countries like China. These findings demonstrate a novel mechanism for miRNA regulation of poliovirus and other Picornaviridae viruses in host cells, and thereby may provide a novel approach in combating infection and a potential approach for the development of anti-Picornaviridae strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Orr-Burks</LastName><ForeName>Nichole Lynn</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia 30602, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shim</LastName><ForeName>Byoung-Shik</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia 30602, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Weilin</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia 30602, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakre</LastName><ForeName>Abhijeet A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia 30602, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karpilow</LastName><ForeName>Jon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Proventus Bio, 220 Riverbend Rd, Athens, Georgia 30602, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripp</LastName><ForeName>Ralph A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia 30602, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064886">Dataset</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Data</MedlineTA><NlmUniqueID>101640192</NlmUniqueID><ISSNLinking>2052-4463</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C569273">MIRN134 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Sci Data. 2017 Mar 01;4:170019. doi: 10.1038/sdata.2017.19</RefSource><PMID Version="1">28248922</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="N">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28248924</ArticleId><ArticleId IdType="pmc">PMC5332013</ArticleId><ArticleId IdType="doi">10.1038/sdata.2017.23</ArticleId><ArticleId IdType="pii">sdata201723</ArticleId></ArticleIdList><ReferenceList><Title>Data Citations</Title><Reference><Citation>Orr-Burks N., Shim B., Wu W., Bakre A., Tripp R. 2017. NCBI PubChem BioAssay. 1224906</Citation></Reference><Reference><Citation>Orr-Burks N., Shim B., Wu W., Bakre A., Tripp R. 2017. NCBI PubChem BioAssay. 1224851</Citation></Reference></ReferenceList><ReferenceList><Reference><Citation>Guo J., Bolivar-Wagers S., Srinivas N., Holubar M. &amp; Maldonado Y. Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication. Vaccine 33, 1235&#x2013;1242 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5529169</ArticleId><ArticleId IdType="pubmed">25600519</ArticleId></ArticleIdList></Reference><Reference><Citation>Minor P. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication. Vaccine 27, 2649&#x2013;2652 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19428874</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong S. S., Yip C. C., Lau S. K. &amp; Yuen K. Y. Human enterovirus 71 and hand, foot and mouth disease. Epidemiol Infect 138, 1071&#x2013;1089 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20056019</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z. &amp; Wang J. EV71 vaccine, an invaluable gift for children. Clin Transl Immunology 3, e28 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4237031</ArticleId><ArticleId IdType="pubmed">25505956</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel D. P. MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell Press 116, 281&#x2013;297 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14744438</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipowicz W., Bhattacharyya S. N. &amp; Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature reviews. Genetics 9, 102&#x2013;114 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18197166</ArticleId></ArticleIdList></Reference><Reference><Citation>Skalsky R. L. &amp; Cullen B. R. Viruses, microRNAs, and host interactions. Annual review of microbiology 64, 123&#x2013;141 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3621958</ArticleId><ArticleId IdType="pubmed">20477536</ArticleId></ArticleIdList></Reference><Reference><Citation>Umbach J. L. &amp; Cullen B. R. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes &amp; development 23, 1151&#x2013;1164 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763533</ArticleId><ArticleId IdType="pubmed">19451215</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X. et al. MicroRNA identification based on sequence and structure alignment. Bioinformatics 21, 3610&#x2013;3614 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15994192</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller S. &amp; Imler J. L. Dicing with viruses: microRNAs as antiviral factors. Immunity 27, 1&#x2013;3 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17663977</ArticleId></ArticleIdList></Reference><Reference><Citation>Trobaugh D. W. et al. RNA viruses can hijack vertebrate microRNAs to suppress innate immunity. Nature 506, 245&#x2013;248 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4349380</ArticleId><ArticleId IdType="pubmed">24352241</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng M. et al. High-Throughput Profiling of Alpha Interferon- and Interleukin-28B- Regulated MicroRNAs and Identification of let-7s with Anti-Hepatitis C Virus Activity by Targeting IGF2BP1. Journal of virology 87, 9707&#x2013;9718 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3754137</ArticleId><ArticleId IdType="pubmed">23824794</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J. Y. et al. MicroRNA-130a can inhibit hepatitis B virus replication via targeting PGC1alpha and PPARgamma. Rna 21, 385&#x2013;400 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4338335</ArticleId><ArticleId IdType="pubmed">25595716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanov A. P. ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines. Expert Review Vaccines 4, 167&#x2013;172 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15889990</ArticleId></ArticleIdList></Reference><Reference><Citation>Nibbeling R. A poliovirus type-specific IgM antibody-capture enzyme-linked immunosorbent assay for the rapid diagnosis of poliomyelitis. Clinical and Diagnostic Virology 2, 113&#x2013;126 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">15566759</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W. F. et al. Host MicroRNA miR-197 Plays a Negative Regulatory Role in the Enterovirus 71 Infectious Cycle by Targeting the RAN Protein. Journal of virology 90, 1424&#x2013;1438 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4719623</ArticleId><ArticleId IdType="pubmed">26581983</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim L. P. et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769&#x2013;773 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15685193</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z. et al. Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. Journal of virology 87, 5645&#x2013;5656 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3648165</ArticleId><ArticleId IdType="pubmed">23468506</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M., Wakita T. &amp; Shimizu H. Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. The Journal of general virology 89, 2518&#x2013;2530 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18796721</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakre A. et al. Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs. PLoS ONE 8, e66796 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3689682</ArticleId><ArticleId IdType="pubmed">23805279</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns C. C. et al. Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region. Journal of virology 80, 3259&#x2013;3272 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1440415</ArticleId><ArticleId IdType="pubmed">16537593</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim B. S. et al. MicroRNA-555 has potent antiviral properties against poliovirus. The Journal of general virology 97, 659&#x2013;668 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26683768</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sanden S. M. et al. Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game. Journal of virology 90, 1694&#x2013;1704 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4733985</ArticleId><ArticleId IdType="pubmed">26581994</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>